Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
Statistics in Medicine · 2025
DOI: 10.1002/sim.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Xiaotian Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Statistical Innovation Group, AbbVie Inc., North Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
The importance of covariate adjustment in clinical trials has been underscored by the U.S. FDA's guidance. Inference, with or without covariates, after implementing covariate adaptive randomization (CAR), is garnering increased interest. This paper investigates the sequential monitoring of covariate‐adaptive randomized clinical trials through non‐parametric methods, a critical advancement for enhancing the precision and efficiency of medical research. CAR, which incorporates baseline patient characteristics into the randomization process, aims to mitigate the risk of confounding and improve the balance of covariates across treatment groups, thereby addressing patients' heterogeneity. Although CAR is known for its benefits in reducing biases and enhancing statistical power, its integration into sequentially monitored clinical trials—a standard practice—poses methodological challenges, particularly in controlling the type I error rate. By employing a non‐parametric approach, we demonstrate through theoretical proofs and numerical analyses that our methods effectively control the type I error rate and surpass traditional randomization and analysis methods. This paper not only fills a gap in the literature on sequential monitoring of CAR without model misspecification but also proposes practical solutions for enhancing trial design and analysis, thereby contributing significantly to the field of clinical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Statistical Innovation Group, AbbVie Inc., North Chicago, Illinois, USA.
- Medical Affairs and Health Technology Assessment Statistics, AbbVie Inc., Virtual Office, Sugar Land, Texas, USA.
- Statistical Innovation Group, AbbVie Inc., Virtual Office, Sugar Land, Texas, USA.
ORCID-Profile: Xiaotian Chen, Hongjian Zhu
Zitieren
APA
Chen, X., Yu, J., Zhu, H., & Wang, L. (2025). Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches. Statistics in Medicine. https://doi.org/10.1002/sim.70042
Vancouver
Chen X, Yu J, Zhu H, Wang L. Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches. Statistics in Medicine. 2025. doi:10.1002/sim.70042
BibTeX
@article{Chen2025,
author = {Chen, Xiaotian and Yu, Jun and Zhu, Hongjian and Wang, Li},
title = {Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70042}
}
EUVIMED